Compounding pharmacy Greenwich Rx is recalling injectable products sold nationwide because they may contain high levels of bacterial toxins, according to an Oct. 1 Food and Drug Administration notice.
The injections contain glutathione, an antioxidant used for liver support and in wellness treatments targeting anti-aging and skin health. They were distributed directly to consumers nationwide.
The products may contain elevated levels of endotoxins, toxins released by certain bacteria. Injecting them can cause fever, low blood pressure, inflammatory reactions, anaphylactic shock and death, according to the FDA.
As of the Oct. 1 notice, Greenwich Rx had received two reports of adverse reactions that led to emergency department treatment. The company said the reactions were due to improper administration.
Which Injectable Drugs Were Recalled?
The affected medication was distributed to patients nationwide between June 26 and Sept. 21, 2026.
- Greenwich Rx Glutathione Injection, 200 mg/mL, in 10 mL packages.
- Lot numbers: 0060-062426-1, 0060-062726-1, 0060-070926-1, 0060-071426-1, 0060-071426-2, 0060-072026-1, 0060-072726-1, 0060-072926-1, 0060-073126-1 and 0060-080426-1.
- Beyond-use dates: Oct. 2, Oct. 5, Oct. 17, Oct. 22 (two lots), Oct. 28, Nov. 4, Nov. 6, Nov. 8 and Nov. 12, 2026.
What to Do With Recalled Medications
Consumers who have the recalled injectables should stop using them and discard them immediately. Greenwich Rx is notifying distributors and customers by email and arranging disposal of the products.
Customers with questions can call 866-552-4916 or email [email protected]. Anyone experiencing potential side effects should contact a health care provider. The FDA says adverse reactions or product-quality problems can be reported through its MedWatch program at fda.gov/medwatch/report.htm.
What to Know About Compounding Pharmacies
Compounding pharmacies create customized medications from raw ingredients. They may adjust a dose or remove ingredients such as dyes to meet a patient’s needs, and can make medicines in different forms, including lower-concentration liquids for children or animals.
Compounded drugs are sometimes used during drug shortages. In 2022, the FDA allowed compounders to produce versions of certain drugs amid shortages. Tirzepatide and semaglutide were removed from the official drug shortage list in late 2024 and early 2025, but compounders have continued producing versions of the drugs.
Compounding pharmacies must use FDA-approved ingredients, but compounded formulations are not evaluated for purity, safety or effectiveness in the same way as mass-produced drugs. They also are not routinely FDA-regulated, which has contributed to contamination concerns.
To check whether a compounding pharmacy is reputable, consult the Alliance for Pharmacy Compounding and speak with your doctor.
Add a Comment